Bioplus (CEO Jeong Hyeon-gyu) announced that it participated in the Spanish Society of Dermatology and Aesthetics (SEME congress) held in Malaga, Spain from the 13th to the 15th and introduced DeneB filler. As the filler business has become Bioplus’ main business since last year, the company plans to expand its global presence through participation in conferences, etc.
The Spanish Society of Aesthetic Dermatology (SEME congress) is an academic exhibition that has led the development of aesthetic medicine in Europe and the Spanish cultural sphere, and is a place where industry experts share various information through educational programs, academic conferences, and presentations.
Bioplus participated in this conference and gave a presentation on one of its products, DeneB filler, and gave a presentation on its procedures. It shared its clinical experience and feedback with the medical staff and industry professionals attending the conference, and explained that it promoted its products and strengthened its brand position in the European and South American medical markets through interviews with Key Opinion Leaders (KOLs).
A company official said, “Participating in this conference has served as an opportunity to solidify relationships with existing business partners and medical professionals who use our products, and to enhance Bioplus’ competitiveness in the aesthetic medicine market by utilizing our local network.”
He added, “We are currently in the process of negotiating a new business partner contract in the Argentine market, so we expect to be able to speed up the supply chain acquisition process. In particular, we expect that securing KOLs this time will help us strengthen our network and give strength to our marketing.”
“Through meetings with global industry insiders and medical professionals, we were able to confirm that our products are being used not only in skin beauty filler treatments but also in various medical fields, and we were able to confirm once again our high brand awareness in Europe,” said Hwang Young-ki, head of the Global Business Division at Bioplus. “We will continue to release various products that meet market demand and lead growth while contributing to the development of the global aesthetic medicine field.”
Bioplus is focusing on discovering global customers and expanding its supply chain through continuous participation in academic conferences and exhibitions, and plans to create new sales channels through new product development.
- See more related articles
You must be logged in to post a comment.